Although not currently used for clinical treatment of advanced PCa, PTX is commonly used in the treatment of other tumor types [48], and it was therefore important to determine if DTX-resistant cancer cells overexpressing LEDGF/p75 also promote resistance to this parental taxane. The gene discussed is PSIP1; the disease is cancer.